Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis

NCT01856205 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Japanese Encephalitis

Interventions

DRUG: Intravenous immunoglobulin [ImmunoRel™ (batch 20081217)]

Sponsor

University of Liverpool

Collaborators

[object Object]
[object Object]